WELLINGTON MANAGEMENT GROUP LLP - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$34,432,000
+5.3%
23,583,115
+2.4%
0.01%0.0%
Q4 2016$32,710,000
-26.9%
23,035,452
-9.9%
0.01%
-27.3%
Q3 2016$44,748,000
-2.1%
25,570,751
-4.3%
0.01%
-8.3%
Q2 2016$45,701,000
-13.3%
26,725,936
-0.2%
0.01%
-14.3%
Q1 2016$52,741,000
+10.9%
26,772,026
+7.0%
0.01%
+16.7%
Q4 2015$47,558,000
-26.6%
25,030,751
-26.2%
0.01%
-33.3%
Q3 2015$64,767,000
-58.8%
33,909,459
+0.1%
0.02%
-56.1%
Q2 2015$157,230,000
+6.4%
33,885,551
+0.2%
0.04%
+7.9%
Q1 2015$147,719,000
+46.3%
33,802,464
+16.2%
0.04%
+40.7%
Q4 2014$100,984,000
-18.7%
29,101,919
-1.8%
0.03%
-20.6%
Q3 2014$124,141,000
-24.1%
29,627,959
+6.2%
0.03%
-22.7%
Q2 2014$163,455,000
-5.8%
27,893,387
+1.2%
0.04%
-8.3%
Q1 2014$173,561,000
-1.2%
27,549,128
-8.2%
0.05%
-5.9%
Q4 2013$175,640,000
+21.3%
30,024,014
+9.3%
0.05%
+13.3%
Q3 2013$144,781,000
-24.2%
27,472,516
+10.7%
0.04%
-27.4%
Q2 2013$191,028,00024,808,8780.06%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 10,500,000$17,955,0000.87%
SENZAR ASSET MANAGEMENT, LLC 1,872,191$3,201,447,0000.70%
Virtus ETF Advisers LLC 277,607$475,0000.35%
GLOBEFLEX CAPITAL L P 571,500$977,0000.27%
Lyons Wealth Management, LLC. 42,408$73,0000.11%
TFS CAPITAL LLC 222,736$381,0000.07%
Jacobi Capital Management LLC 35,000$56,0000.03%
Renaissance Technologies 5,601,355$9,578,0000.02%
WELLINGTON MANAGEMENT GROUP LLP 26,725,936$45,701,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 46,300$79,0000.01%
View complete list of ARENA PHARMACEUTICALS INC shareholders